Michel Dahan Akebia Therapeutics, Inc. (AKBA) insider trading activity
Michel Dahan is SVP, Chief Operating Officer of Akebia Therapeutics, Inc.. Currently has a direct ownership of 672,092 shares of AKBA, which is worth approximately $1.29 Million. The most recent transaction as insider was on May 13, 2024, when has been sold 34,840 shares (Common Stock) at a price of $1.26 per share, resulting in proceeds of $43,898. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
672K
0%
3M change
17.08%
12M change
Total Value Held
$1.29 Million
Michel Dahan Transaction History
MD
Michel Dahan
SVP, Chief Operating Officer
Cambridge, MA